These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32691670)

  • 1. Overcoming Barriers: Individual Experiences Obtaining Medication-Assisted Treatment for Opioid Use Disorder.
    Scorsone KL; Haozous EA; Hayes L; Cox KJ
    Qual Health Res; 2020 Nov; 30(13):2103-2117. PubMed ID: 32691670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.
    Cole ES; DiDomenico E; Cochran G; Gordon AJ; Gellad WF; Pringle J; Warwick J; Chang CH; Kim JY; Kmiec J; Kelley D; Donohue JM
    J Gen Intern Med; 2019 Jun; 34(6):936-943. PubMed ID: 30887440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.
    Cochran G; Cole ES; Warwick J; Donohue JM; Gordon AJ; Gellad WF; Bear T; Kelley D; DiDomenico E; Pringle J
    Addict Sci Clin Pract; 2019 Aug; 14(1):25. PubMed ID: 31366408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and perceived usefulness of an ECHO intervention for office-based buprenorphine treatment for opioid use disorder in North Carolina: A qualitative study.
    Shea CM; Gertner AK; Green SL
    Subst Abus; 2021; 42(1):54-64. PubMed ID: 31809679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
    Higgins TM; Goodman DJ; Meyer MC
    Prev Med; 2019 Nov; 128():105786. PubMed ID: 31356827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ending the Chase: Experiences of Rural Individuals with Opioid Use Disorder.
    Scorsone KL; Haozous EA; Hayes L; Cox KJ
    Subst Use Misuse; 2021; 56(8):1224-1231. PubMed ID: 33871309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

  • 8. The Balance Between Serving the Community and the Reality of Treating Opioid Use Disorder in Rural Primary Care Practices.
    Holtrop JS; Mullen R; Curcija K; Westfall JM; Zittleman L
    J Health Care Poor Underserved; 2022; 33(1):253-267. PubMed ID: 35153218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does a Rural Community-Based Intervention Improve Knowledge and Attitudes of Opioid Use Disorder and Medication-Assisted Treatment? A Report From the IT MATTTRs Study.
    Curcija K; Zittleman L; Fisher M; Nease DE; Dickinson LM; de la Cerda D; Sutter C; Ancona J; Rank J; Westfall JM
    J Rural Health; 2022 Jan; 38(1):120-128. PubMed ID: 33244841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.
    Choi S; Yerneni R; Healy S; Goyal M; Neighbors CJ
    Am J Addict; 2020 Mar; 29(2):151-154. PubMed ID: 31951083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder.
    Chai D; Rosic T; Panesar B; Sanger N; van Reekum EA; Marsh DC; Worster A; Thabane L; Samaan Z
    JAMA Netw Open; 2021 Aug; 4(8):e2119600. PubMed ID: 34351402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
    Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
    Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Of Opioid Use Disorder Among Commercially Insured US Adults, 2008-17.
    Shen K; Barrette E; Dafny LS
    Health Aff (Millwood); 2020 Jun; 39(6):993-1001. PubMed ID: 32479213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.
    Deyo-Svendsen M; Cabrera Svendsen M; Walker J; Hodges A; Oldfather R; Mansukhani MP
    J Prim Care Community Health; 2020; 11():2150132720931720. PubMed ID: 32507023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Projected Contributions of Nurse Practitioners and Physicians Assistant to Buprenorphine Treatment Services for Opioid Use Disorder in Rural Areas.
    Andrilla CHA; Patterson DG; Moore TE; Coulthard C; Larson EH
    Med Care Res Rev; 2020 Apr; 77(2):208-216. PubMed ID: 30089426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
    McElrath K; Joseph H
    Subst Use Misuse; 2018 Jan; 53(2):177-180. PubMed ID: 29220615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment.
    Scott CK; Dennis ML; Grella CE; Kurz R; Sumpter J; Nicholson L; Funk RR
    J Subst Abuse Treat; 2020 Jan; 108():75-81. PubMed ID: 31399271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol.
    Sanger N; Shahid H; Dennis BB; Hudson J; Marsh D; Sanger S; Worster A; Teed R; Rieb L; Tugwell P; Hutton B; Shea B; Beaton D; Corace K; Rice D; Maxwell L; Samaan MC; de Souza RJ; Thabane L; Samaan Z
    BMJ Open; 2018 Dec; 8(12):e025059. PubMed ID: 30518592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.